Event Participants
Executives
5 Dharmil A. Bodani, Girish Khandelwal, Kiranpreet Gill, Parag Satoskar, Shyamal Bodani
Analysts
8 Anisha Dalal, Maitri Shah, Moksh Ranka, Rajesh Mishra, Rohit Sinha, Saket Saurabh, Shubhi Gupta, Vinayak
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Operating Revenue | ₹260 crores | +15% YoY vs ₹226 cr Q1 FY26; -8% QoQ due to product mix changes |
| Sales Volume | +22% YoY | Driven by healthy demand; QoQ broadly stable with seasonal and mix effects |
| Production Volume | +18% YoY | Reflected improved manufacturing utilization and execution |
| EBITDA | ₹19.8 crores | vs ₹18.06 cr Q1 FY26; vs ₹19.46 cr Q4 FY26 |
| EBITDA Margin | 7.62% | +71 bps QoQ from 6.89%; -39 bps YoY due to higher raw material costs |
| PAT | ₹2.51 crores | vs ₹0.5 cr Q1 FY26; vs ₹3.98 cr Q4 FY26 |
| Cash Profit | ₹10.2 crores | vs ₹8.72 cr Q1 FY26; vs ₹11.72 cr Q4 FY26 |
| Net Debt to Equity | 0.56x | Improved from 0.58x as of March 31, 2026 |
| Export Contribution | 35% of revenue | Up from 33% in FY26; expected to stay in similar range |
Geographic & Segment Commentary
Fragrance & Flavors: Resilient performance with healthy customer demand; Ambarnath production/sales volumes marginally lower YoY due to seasonality, not a change in direction. Brief pipeline healthy with focus on deepening relationships, wallet share and converting development projects into sustainable commercial business.
Specialty Aroma Ingredients: Healthy YoY growth in production and sales volumes, but global market remains highly competitive with Asian capacity additions pressuring prices. Input costs firm; company responding through process re-engineering, yield improvement, energy optimization and selective business pursuit to protect contribution margins.
Camphor & Terpene Chemicals: Strong YoY volume growth with inventory buildup ahead of Q2/Q3 festive demand. Structural overcapacity in domestic camphor market persists; focus on pharma-grade product, strategic B2B relationships and Saraswati/3 Pine consumer brands.
Mahad Facility: Operating at 50-60% utilization; customer feedback encouraging, commercial shipments progressing and facility participating in global sourcing programs/RFQs. Target of 75-80% utilization for EBITDA positivity and meaningful consolidated contribution.
Company-Specific & Strategic Commentary
Backward Integration Advantage: Management emphasized that capex-driven ingredient investments strengthen the fragrance division's competitive positioning; integrated multi-chemistry platform supports security of supply for customers amid geopolitical uncertainty and supply chain disruptions.
Operational Efficiency Programs: Focus on process re-engineering, yield improvement, energy optimization, internalization of intermediates and greater multi-chemistry platform utilization to improve cost position independent of any pricing cycle recovery.
Capital Discipline: Net debt to equity improved to 0.56x; immediate priority is maximizing utilization and profitability from existing assets before undertaking major expansionary investments.
R&D Investment: Current spend at ~2-2.5% of sales; selective investment in fragrance creation, application, and new product development to strengthen long-term competitive position.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| Sales growth (next 12 months) | 10-15% | Near-term goal based on current capacity, active pipeline and operational trajectory |
| Mahad utilization | 75-80% target | Level expected to make facility EBITDA positive and contribute meaningfully to consolidated profitability |
| Export contribution | ~33-35% of revenue | Expected to remain in similar range going forward |
| Effective tax rate (FY27) | ~25% | Parent company rate; OSN has no tax liability |
| Seasonality | Q2/Q3 strong | Festive demand period important for camphor and consumer fragrances |
Risks & Constraints
| Risk | Context |
|---|---|
| Raw material inflation | Alpha-pinene prices up 70-80% in past five months and remain firm; petrochemical inputs in a seesaw pattern. Management pursuing pass-throughs and operational efficiencies, but specialty ingredients and camphor spaces face pass-through challenges due to competitive market |
| Competitive pricing pressure | Significant capacity additions across Asia, particularly China, keep a buyer's market in generic ingredients; limiting price recovery and pressuring EBITDA margins (down 39 bps YoY despite volume growth) |
| Camphor overcapacity | Structural overcapacity from recent domestic capacity additions; finished product market has limited CAGR, making industry coordination on pricing difficult |
| Mahad under-utilization | Facility at 50-60% utilization not absorbing fixed operating costs; inventory buildup initiated due to challenged access to petro-driven raw material; profitability constrained until utilization ramps |
| Geopolitical supply chain | West Asia crisis and geopolitical uncertainty disrupting raw material access; company leveraging long-term supplier relationships and strategic buy/no-buy decisions to mitigate impact |
Q&A Highlights
Capacity Utilization & Growth
- Question: What's current utilization across plants and peak revenue potential? When will Mahad ramp up? (Rohit Sinha, Sunidhi Securities)
- Answer: Mahad at 50-60%; most other specialty aroma and camphor plants at 85-90%; fragrance compounding has substantial additional capacity. Near-term goal is 10-15% sales growth over next year. (Dharmil Bodani)
Margin Outlook & Raw Material
- Question: How much margin improvement from favorable product mix? Outlook on raw material pressure? (Shubhi Gupta, Trinetra Asset Managers)
- Answer: Margin outlook fluid given geopolitical impact on input availability and pricing; alpha-pinene based materials trending expensive, petro inputs volatile. Company taking calibrated steps balancing raw material availability with lowest cost. (Dharmil Bodani)
- Question: Volume growth 22% vs revenue 15% — realization pressure; how much further can realizations fall? (Maitri Shah, Sapphire Capital)
- Answer: Gap driven by customers taking advance allocations due to geopolitical situation; focus on targeting volume growth at decent contribution margins. Pass-throughs successful where possible, with step-up mechanisms covering FX and raw material hikes. (Dharmil Bodani)
Camphor Industry Coordination
- Question: Why don't camphor manufacturers coordinate to correct pricing? (Anisha Dalal, Universal Capital)
- Answer: Demand-supply gap from excess capacity far exceeding finished product CAGR makes coordination very challenging; everyone is competing for a non-growing pie. Management acknowledged the suggestion and will evaluate. (Dharmil Bodani)
Brand Contribution
- Question: Contribution of Saraswati and 3 Pine brands to camphor division? (Moksh Ranka, Aurum Capital)
- Answer: Company does not provide individual subdivision breakups; only broad three-vertical contributions disclosed. (Dharmil Bodani)
Export Mix & R&D
- Question: Export contribution in Q1 and FY27 outlook? R&D spend? (Rohit Sinha, Sunidhi Securities)
- Answer: Export contribution 35% in Q1 vs 33% in FY26; expected to stay in similar range. R&D spend at ~2-2.5% of sales. (Girish Khandelwal, Dharmil Bodani)
Mahad Contribution & Margin Sustainability
- Question: Is Mahad contributing only ~₹3 crores quarterly at 50-60% utilization? Is production being inventorized? Margins stuck at ~7% even excluding Mahad — any improvement scope? (Saket Saurabh, Sagari Capital)
- Answer: Mahad had inventory buildup due to challenged petro raw material access; confident of selling in near future. Margin pressure from Asian capacity expansion in generic ingredients; fragrance division benefits from backward integration and expanding product basket; company well-positioned to capitalize when opportunities emerge. (Dharmil Bodani)
Raw Material Crisis Management
- Question: How did the company manage the significant volatility from the West Asia crisis? (Vinayak, Individual Investor)
- Answer: Combination of vigilant supplier communication, long-term relationships, and a dedicated team making strategic long/short buying decisions across the raw material portfolio in all three divisions. (Dharmil Bodani)
Key Takeaway
Oriental Aromatics delivered a positive start to FY27 with operating revenue of ₹260 crores (+15% YoY), driven by 22% volume growth and 18% production growth, while EBITDA margin improved 71 bps sequentially to 7.62% though declined 39 bps YoY on elevated raw material costs. PAT stood at ₹2.51 crores and net debt-to-equity improved to 0.56x. Management emphasized disciplined execution across three divisions — Fragrance & Flavors, Specialty Aroma Ingredients, and Camphor & Terpene Chemicals — with the Mahad facility progressing at 50-60% utilization toward a 75-80% target for EBITDA positivity. Strategy centers on backward integration into fragrance, operational efficiency programs, and selective business pursuit amid competitive Asian capacity additions and alpha-pinene inflation (up 70-80% over five months, remaining firm). Near-term guidance of 10-15% revenue growth over the next year, export contribution stable at 33-35%, and effective tax rate around 25% frame the outlook. Key watchpoints remain raw material cost trajectory, Mahad commercialization pace, and pricing dynamics in generic ingredient and camphor markets.